LONDON (AFP) – Clinical trials on one of the most advanced experimental COVID-19 vaccines, which is being developed by pharmaceutical company AstraZeneca and Oxford University, were “paused” on Tuesday after a volunteer developed an unexplained illness.
With billions of people around the world still suffering with the fallout of the pandemic and the global death toll nearing 900,000, a worldwide race for a vaccine is underway, with nine companies already in late-stage Phase 3 trials.
More details on Thursday’s Borneo Bulletin
